Measuring RNFL thickness

Article

Operator-dependent centring and automatic centring retinal nerve fibre layer (RNFL) thickness measurement patterns (RNFL3.45 and NHM4) have been shown to be in good agreement.

Operator-dependent centring and automatic centring retinal nerve fibre layer (RNFL) thickness measurement patterns (RNFL3.45 and NHM4) have been shown to be in good agreement, according to a study published in Clinical and Experimental Ophthalmology.

Dr Shuning Li et al., Beijing Ophthalmology and Visual Science Laboratory, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, China, conducted a cross-sectional observational study on 153 eyes of 149 patients. RNFL3.45 and NHM4 were used to measure retinal nerve fibre layer thickness three times daily. The outcome measures were Student's paired t-test, intra-class correlation coefficient, and coefficient of variation, test–retest viability, Pearson's correlation coefficient and Bland–Altman analysis of RNFL thickness measurements.

Paired t-testing demonstrated that the difference between RNFL3.45 and NHM4 measurements were statistically significant in the severe glaucoma group. The Pearson's correlation test revealed a strong correlation of the mean RNFL.

Bland–Altman plots revealed that the differences between RNFL3.45 and NHM4 were larger at thinner RNFL values, but smaller at thicker RNFL values. The intra-class correlation coefficient for RNFL3.45 in control patients and glaucoma patients was 0.990 and 0.997, respectively. For NHM4 the intra-class correlation coefficient was 0.989 and 0.995 for the control patients and glaucoma patients, respectively.

RNFL3.45 and NHM4 are both sufficient methods for RNFL thickness.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.